Endovascular Therapy of Acute Ischemic Stroke in Patients with Large-Vessel Occlusion Associated with Active Malignancy.
Adult
Aged
Aged, 80 and over
Databases, Factual
Endovascular Procedures
/ adverse effects
Female
Fibrinolytic Agents
/ administration & dosage
Humans
Infusions, Intravenous
Ischemic Stroke
/ complications
Male
Middle Aged
Neoplasms
/ complications
Retrospective Studies
Stents
Thrombectomy
/ adverse effects
Thrombolytic Therapy
/ adverse effects
Time Factors
Tissue Plasminogen Activator
/ administration & dosage
Treatment Outcome
Vascular Access Devices
Active malignancy
Acute ischemic stroke
Endovascular therapy
Large vessel occlusion
Journal
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
17
10
2020
revised:
29
10
2020
accepted:
30
10
2020
pubmed:
27
11
2020
medline:
26
1
2021
entrez:
26
11
2020
Statut:
ppublish
Résumé
There is limited data on the effectiveness of endovascular therapy (EVT) in stroke patients with active malignancy. In this study, we investigated the outcome of EVT for acute ischemic stroke for patients with active malignancy compared to those without malignancy. We selected patients who underwent EVT for acute ischemic stroke between January 2015 and July 2019. Patients were divided into two groups, those with active malignancy (oncology group - OG) and those without (non-oncology group, NOG). 300 patients were included in this study. There were 19 EVT procedures (18 patients) in the OG and 285 procedures (282 patients) in the NOG. There was no difference in recanalization success rate (mTICI 2b & 3) between the groups: 94.7% versus 80.9% in OG and NOG respectively (p = 0.13). Success rate using the direct aspiration (ADAPT) technique of EVT was not different between compared groups (42.9% versus 67.7%; p = 0.18). However, when using smaller-caliber aspiration devices, ADAPT was less successful in OG (0.0% versus 64.7%, p < 0.05). There was no difference in recanalization success rate of EVT when using a stent-retriever or combined technique. Patients in the OG had a less favorable functional outcome than in the NOG group (mRS 0-2 at 90-days post event: 22.2% versus 48.2%, p < 0.05) CONCLUSION: The technical success rate of EVT in patients with active malignancy is similar to the general population of stroke patients. Interestingly, the success rate of EVT using the ADAPT technique was lower in the OG when using smaller caliber aspiration devices.
Identifiants
pubmed: 33242784
pii: S1052-3057(20)30873-9
doi: 10.1016/j.jstrokecerebrovasdis.2020.105455
pii:
doi:
Substances chimiques
Fibrinolytic Agents
0
Tissue Plasminogen Activator
EC 3.4.21.68
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105455Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.